Special Issue "Recent Advances in Fetal Alcohol Spectrum Disorder (FASD)"
Deadline for manuscript submissions: closed (15 December 2020) | Viewed by 27551
2. Scientist, Faculty at Columbia University Medical Center, Center for Dementia Research, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA
Interests: endocannabinoids; synaptic plasticity; FASD; AUD; neurodegeneration; learning and memory; epigenetics; gene expression; behavior
Special Issues, Collections and Topics in MDPI journals
Special Issue in Brain Sciences: Pathogenesis and Treatment of Neurodegenerative Diseases
Special Issue in Diseases: Neuro-psychiatric Disorders - Feature Paper
Special Issue in Brain Sciences: New Advances in Neurobiology and Behavioral Disturbance in Alcohol Use Disorder (AUD) including Fetal Alcohol Spectrum Disorder (FASD)
Special Issue in Biomolecules: New Advances of Cannabinoid Receptors in Health and Disease
Fetal alcohol spectrum disorder (FASD) is a disability in a child that results from alcohol exposure during the mother's pregnancy. FASD signs and symptoms may include any combination of physical defects, intellectual or cognitive disabilities, and difficulties functioning, interacting with others, and managing daily life. Alcohol exposure during pregnancy and its influence on offspring have been acknowledged for centuries, but only lately have we started to gain an understanding of the molecular mechanisms involved in FASD. The severity of FASD is influenced by the level of alcohol exposure, the developmental age, and the duration of the exposure (chronic vs. acute). In this regard, several studies in recent years have brought to light the critical role of different signaling receptors, epigenetic changes, and gene expression pathways in cognitive function. The aim of this Special Issue is to take stock of recent advancements and compare different molecular pathways and pharmacology strategies that can interact at both the cellular and behavioral levels.
We welcome both original basic or translation research papers and short communications presenting data that have a significant impact on our understanding of FASD. Also of interest are reviews that focus on molecular mechanisms involved in FASD or the impact of potential drugs that target behavioral outcomes.
Dr. Balapal S. Basavarajappa
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Learning and Memory
- Synaptic Plasticity